BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Natsuda K, Takatsuki M, Tanaka T, Soyama A, Adachi T, Ono S, Hara T, Baimakhanov Z, Imamura H, Okada S, Hidaka M, Eguchi S. Aspartate transaminase-platelet ratio and Fibrosis-4 indices as effective markers for monitoring esophageal varices in HIV/hepatitis C virus co-infected patients due to contaminated blood products for hemophilia: APRI and FIB4 in HIV/HCV co-infected patients. Hepatol Res 2017;47:1282-8. [DOI: 10.1111/hepr.12866] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Nishimura T, Iijima H, Nishikawa H, Kondo R, Yano H, Kage M, Aoki T, Nakano C, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Takashima T, Aizawa N, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S. Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases. Hepatol Res 2019;49:721-30. [PMID: 30884015 DOI: 10.1111/hepr.13332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Eguchi S, Hidaka M, Natsuda K, Hara T, Kugiyama T, Hamada T, Tanaka T, Ono S, Adachi T, Kanetaka K, Soyama A, Mochizuki Y, Sakai H. Simultaneous Deceased Donor Liver and Kidney Transplantation in a Human Immunodeficiency Virus/Hepatitis C Virus -Coinfected Patient With Hemophilia in Japan: A Case Report. Transplant Proc 2020;52:2786-9. [PMID: 32522360 DOI: 10.1016/j.transproceed.2020.05.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Eguchi S, Egawa H, Eguchi H, Uehira T, Endo T, Genda T, Shinoda M, Hasegawa K, Shimamura T, Tsukada K, Hara T, Nakao K, Yatsuhashi H, Yotsuyanagi H, Natsuda K, Soyama A, Hidaka M, Hara T, Takatsuki M. Indications and waiting list priority for deceased donor liver transplantation in HIV/HCV co-infected hemophilic patients in Japan through contaminated blood product. Hepatol Res 2021;51:909-14. [PMID: 34132462 DOI: 10.1111/hepr.13686] [Reference Citation Analysis]
4 Yoshimoto T, Eguchi S, Natsuda K, Hidaka M, Adachi T, Ono S, Hamada T, Huang Y, Kanetaka K, Takatsuki M. Relationship between various hepatic function scores and the formation of esophageal varices in patients with HIV/hepatitis C virus co-infection due to contaminated blood products for hemophilia: Hepatic function scores in HIV/HCV co-infection. Hepatol Res 2019;49:147-52. [DOI: 10.1111/hepr.13279] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Takatsuki M, Yamasaki K, Natsuda K, Hidaka M, Ono S, Adachi T, Yatsuhashi H, Eguchi S. Wisteria floribunda agglutinin-positive human Mac-2-binding protein as a predictive marker of liver fibrosis in human immunodeficiency virus/hepatitis C virus coinfected patients. Hepatol Res 2020;50:419-25. [PMID: 31785125 DOI: 10.1111/hepr.13468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hidaka M, Eguchi S, Hara T, Soyama A, Okada S, Hamada T, Ono S, Adachi T, Kanetaka K, Takatsuki M. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. J Invest Surg 2020;33:118-22. [PMID: 29856668 DOI: 10.1080/08941939.2018.1476631] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Ishida H, Ishihara A, Tanaka S, Iwasaki T, Hasegawa H, Akasaka T, Sakakibara Y, Nakazuru S, Uehira T, Shirasaka T, Mita E. Favorable outcome with direct-acting antiviral treatment in hepatitis C patients coinfected with HIV. Hepatol Res 2019;49:1076-82. [PMID: 31074580 DOI: 10.1111/hepr.13360] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]